HSA — authorised 31 July 2014
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
🇸🇬 Striverdi Respimat in Singapore
HSA authorised Striverdi Respimat on 31 July 2014
Marketing authorisation
Striverdi Respimat in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Singapore
Frequently asked questions
Is Striverdi Respimat approved in Singapore?
Yes. HSA authorised it on 31 July 2014.
Who is the marketing authorisation holder for Striverdi Respimat in Singapore?
BOEHRINGER INGELHEIM holds the Singaporean marketing authorisation.